Skip to main content
. 2021 Oct 12;7:137. doi: 10.1038/s41523-021-00343-4

Table 3.

Distribution of HER2 expression by IHC according to tumor phenotype in the HER2-low cohort.

HER2 expression n (%)
1+ 2+ p
Primary breast cancer n (%)
HR-positive/HER2-negative 118 (63.1) 41 (21.9) 0.493
Triple-negative 19 (10.2) 9 (4.8)
Total 137 (73.3) 50 (26.7)
Recurrent breast cancer n (%)
HR-positive/HER2-negative 122 (59.8) 40 (19.6) 0.840
Triple-negative 33 (16.2) 9 (4.4)
Total 155 (76.0) 49 (24.0)